Literature DB >> 8263191

Comparison of latex agglutination test with enzyme-linked immunosorbent assay for detection of antibody to varicella-zoster virus.

M L Landry1, D Ferguson.   

Abstract

A new latex agglutination (LA) test (VZVscan; Becton Dickinson, Cockeysville, Md.) was compared with an enzyme-linked immunosorbent assay (ELISA) (Varicella STAT; Whittaker Bioproducts, Walkersville, Md.) for detection of varicella-zoster virus (VZV) antibody. Of 165 samples tested, 126 (76%) were positive by LA, 123 (73%) were positive by ELISA, and 35 (21%) were negative by both methods. Six samples (4%) were LA positive and ELISA negative or equivocal; three samples (2%) were ELISA positive and LA negative. However, LA failed to detect seroconversions in four adults with varicella in samples obtained 14 to 17 days after the onset of rash. These same samples had ELISA values in the high-positive range. In addition, the recommended LA screening dilution (1:2) is not supported by published data and should be changed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8263191      PMCID: PMC266199          DOI: 10.1128/jcm.31.11.3031-3033.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  6 in total

1.  Measurement of antibodies to varicella-zoster virus by using a latex agglutination test.

Authors:  S P Steinberg; A A Gershon
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

2.  Antibody to varicella-zoster virus-induced membrane antigen: immunofluorescence assay using monodisperse glutaraldehyde-fixed target cells.

Authors:  J A Zaia; M N Oxman
Journal:  J Infect Dis       Date:  1977-10       Impact factor: 5.226

3.  Comparison of fluorescent-antibody-to-membrane-antigen test, indirect immunofluorescence assay, and a commercial enzyme-linked immunosorbent assay for determination of antibody to varicella-zoster virus.

Authors:  M L Landry; S D Cohen; D R Mayo; C K Fong; W A Andiman
Journal:  J Clin Microbiol       Date:  1987-05       Impact factor: 5.948

4.  Detection of cytomegalovirus antibody with latex agglutination.

Authors:  S P Adler; M McVoy; V G Biro; W J Britt; P Hider; D Marshall
Journal:  J Clin Microbiol       Date:  1985-07       Impact factor: 5.948

5.  Serologic response to varicella-zoster membrane antigens measured by direct immunofluorescence.

Authors:  V Williams; A Gershon; P A Brunell
Journal:  J Infect Dis       Date:  1974-12       Impact factor: 5.226

6.  Enzyme-linked immunosorbent assay for susceptibility to varicella.

Authors:  Z Shehab; P A Brunell
Journal:  J Infect Dis       Date:  1983-09       Impact factor: 5.226

  6 in total
  6 in total

1.  Comparative study of the standard fluorescent antibody to membrane antigen (FAMA) assay and a flow cytometry-adapted FAMA assay to assess immunity to varicella-zoster virus.

Authors:  M M Lafer; L Y Weckx; M I de Moraes-Pinto; A Garretson; S P Steinberg; A A Gershon; P S LaRussa
Journal:  Clin Vaccine Immunol       Date:  2011-05-25

2.  Comparison of two methods for detecting varicella-zoster virus antibody with varicella-zoster virus cell-mediated immunity.

Authors:  A Weinberg; A R Hayward; H B Masters; I A Ogu; M J Levin
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

3.  Determination of varicella-zoster virus (VZV) immune status with the VIDAS VZV immunoglobulin G automated immunoassay and the VZVScan latex agglutination assay.

Authors:  C A Gleaves; K A Schwarz; M B Campbell
Journal:  Clin Diagn Lab Immunol       Date:  1996-05

Review 4.  Varicella-zoster virus.

Authors:  A M Arvin
Journal:  Clin Microbiol Rev       Date:  1996-07       Impact factor: 26.132

Review 5.  Microbiology laboratory and the management of mother-child varicella-zoster virus infection.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2016-08-12

6.  A systematic approach for the identification of novel, serologically reactive recombinant Varicella-Zoster Virus (VZV) antigens.

Authors:  Maria G Vizoso Pinto; Klaus-Ingmar Pfrepper; Tobias Janke; Christina Noelting; Michaela Sander; Angelika Lueking; Juergen Haas; Hans Nitschko; Gundula Jaeger; Armin Baiker
Journal:  Virol J       Date:  2010-07-20       Impact factor: 4.099

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.